Press contact, press kit assets, and company facts for journalists, analysts, and media teams covering engineering technology and built environment innovation.
All press and media enquiries should be directed to our team. We aim to respond within one business day.
Response within 1 business day. For urgent enquiries, state "URGENT — PRESS" in the subject line.
Brand assets, executive biography, and factsheet available on request. Contact us at the address above to receive the press kit.
SVG, PNG, and EPS formats — dark and light backgrounds. Includes usage guidelines.
Typography, colour palette, imagery standards, and tone of voice document.
Official company overview and leadership background. Short (50 words) and long (200 words) versions available.
One-page factsheet — company overview, platform capabilities, markets, and contact details.
Key facts for editorial and analytical use.
| Company Name | Novus Projects Ltd (trading as NOVTRIQ) |
| Company Number | 13629950 (England & Wales) |
| Registered Office | 27 Old Gloucester Street, London WC1N 3AX |
| ICO Registration | ZB304701 |
| VAT Number | GB433633213 |
| Founded | 2021 |
| Headquarters | United Kingdom |
| Markets | United Kingdom (primary), European Union, United Arab Emirates |
| Description | Engineering Intelligence Platform — combining specialist engineering services with AI-augmented tools, compliance intelligence, and API-accessible data for the built environment and critical infrastructure sectors. |
| Free Tools | A suite of free engineering tools and compliance checkers — PUE, EPBD compliance, NIS2 OT checker, Eurocode beam and column, thermal load, building carbon, and more |
| Platform | REST API, MCP Server (AI agent integration), webhook support |
| Data Feed | NOVTRIQ Daily — engineering intelligence briefing (Free, Professional £15/mo, Team £49/mo) |
| Press Contact | hello@novtriq.tech |
| Website | novtriq.tech |
For interviews, technical commentary, or background briefings — contact the NOVTRIQ press team directly.
Contact us About NOVTRIQ